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Abstract
Introduction Sleeve gastrectomy has become a popular
stand-alone bariatric procedure with comparable weight
loss and resolution of comorbidities to that of laparoscopic
gastric bypass. The simplicity of the procedure and the
decreased long-term risk profile make this surgery more
appealing. Nonetheless, the ever present risk of a staple-line
leak is still of great concern and needs further investigation.
Methods An electronic literature search of MEDLINE
database plus manual reference checks of articles published
on laparoscopic sleeve gastrectomy for morbid obesity and
its complications was completed. Keywords used in the
search were ‘‘sleeve gastrectomy’’ OR ‘‘gastric sleeve’’
AND ‘‘leak.’’ We analyzed 29 publications, including
4,888 patients. We analyzed the frequency of leak after
sleeve gastrectomy and its associated risks of causation.
Results The risk of leak after sleeve gastrectomy in all
comers was 2.4%. This risk was 2.9% in the super-obese
[body mass index (BMI) [ 50 kg/m2] and 2.2% for
BMI \ 50 kg/m2. Staple height and use of buttressing
material did not affect leak rate. The use of a size 40-Fr or
greater bougie was associated with a leak rate of 0.6%
compared with those who used smaller sizes whose leak rate
was 2.8%. Leaks were found at the proximal third of the
stomach in 89% of cases. Most leaks were diagnosed after
discharge. Endoscopic management is a viable option for
leaks and was documented in 11% of cases as successful.
Conclusions Sleeve gastrectomy has become an important
surgical option for the treatment of the ever growing mor-
bidly obese population. The risk of leak is low at 2.4%.
Attention to detail specifically at the esophagogastric
junction cannot be stressed enough. Careful patient selec-
tion (BMI \ 50 kg/m2) and adopting the use of a 40-Fr or
larger bougie may decrease the risk of leak. Vigilant follow-
up during the first 30 days is critical to avoid catastrophe,
because most leaks will happen after patient discharge.
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Sleeve gastrectomy has become a common procedure in the
field of bariatric surgery. It was initially used in the super-
obese to get them to a safer weight to undergo a more complex
procedure but many have found sufficient weight loss and
resolution of comorbidities with the sleeve alone [1–3]. The
simplicity of the procedure and the decreased risk profile make
this surgery very appealing. However, the ever present risk of
a staple-line leak is still of great concern and needs further
investigation. This analysis documents the results of 4,888
sleeve gastrectomies performed by surgeons worldwide and
presented in 29 publications from peer-reviewed journals.
These data provide insight into avoiding the complication of
leak and how they can best be managed if encountered.
Materials and methods
An electronic literature search of MEDLINE database plus
manual reference checks of articles published on
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laparoscopic sleeve gastrectomy for morbid obesity and its
complications was completed. Keywords used in the search
were ‘‘sleeve gastrectomy’’ OR ‘‘gastric sleeve’’ AND
‘‘leak.’’ This gave us 459 articles, which were then limited by
the following conditions: human, English, adult, published
during the past 10 years. This decreased the number of
publications to 249. These 249 articles were manually
screened to determine their value in answering our questions:
‘‘What is the risk of leak in sleeve gastrectomy? What are the
associated complications, stricture or bleed? Can these be
avoided?’’ Articles were excluded if their focus was not
sleeve gastrectomy and its complications. We also excluded
review articles, revisional surgery, single-incision, dupli-
cates, and studies with less than 50 patients. This gave us a
final pool of 29 publications that met our criteria and that
demonstrate international experience with 4,888 sleeve
gastrectomy patients and their outcomes (Fig. 1). Because
our interest was in the complications of sleeve gastrectomy,
the data that we collected reflected this interest and included:
BMI, intraoperative leak test, type of staples used, staple-line
buttressing, sizing device used, operative time, leak, stric-
ture, bleeding, the location and time of diagnosis of the
complication and its management, and % excess weight loss.
These data are documented in Table 1. The great majority of
these publications are retrospective chart review case series.
By definition, this makes comparison of the data and its
analysis difficult and the conclusions drawn significantly less
strong than a blinded, randomized, control trial. However,
we feel very strongly that the information, trends, and dif-
ferences found from the analysis of these publications pro-
vide significant information to direct further study on the
topic and perhaps safer surgery with fewer complications.
The data were analyzed by Mann–Whitney nonparametric
method with the assistance of the statistical services avail-
able at University Hospitals Case Medical Center. The dif-
ference was considered significant if P \ 0.05.
Results
From the Medline search, 29 publications provided 4,888
patient records. The mean BMI ranged from 34 to 65.4 kg/m2.
All 29 studies documented a leak rate, which ranged from 0 to
7%. The mean leak rate for all 29 studies was 2.4%, which
accounted for 115 leaks in 4,888 cases of sleeve gastrectomy.
Six studies specifically addressed super-obese patients with a
mean BMI [ 50 kg/m2 [1, 4–6]. In the super-obese, the mean
leak rate was 2.9% or 23 leaks of 771 patients compared with
the leak rate of only 2.2% (92/4,117) for those with mean
BMI \ 50 kg/m2 (not significant P [ 0.05).
Seven studies boasted no leak. These studies had a total
of 1,151 patients. Their mean BMI range was 43–58 kg/
m2. They used different bougie sizes from 32- to 48-Fr to
size their sleeves, and only one used staple-line buttressing
material; however, two of the other six oversewed their
staple lines. These leakless groups for the most part used
two sizes of staples: 4.1–4.5 mm on the distal stomach
(antrum) and 3.5 mm on the proximal body and fundus. Of
these seven leakless publications covering 1,151 patients,
there were only three bleeds and one stricture, which
required reoperation. All seven publications demonstrated
significant excess weight loss [50% at 12 months (only
two reported as EWL the others as excess BMI loss).
Twenty-two studies documented a leak, and this ranged
from 0.7 to 7% and represented 115 of 3,737 patients. The
n ranged from 53 in a U.S. study to 540 patients in a
Spanish study. Of those studies that documented a leak
(76% or 22/29 studies), the location of the leak in the vast
majority (92%, 58/63) was proximal, in the region of the
esophagogastric junction. However, only 50% (11/22
studies) documented the location. Ten of 21 studies (48%)
documented the time of diagnosis. The large majority of
leaks occurred after discharge home. Fifty percent occurred
more than 10 days postoperatively (11–31 days). Nineteen
percent of those with leaks did not disclose the type of
staple load used. For the most part, 71% (15/22) of sur-
geons in groups that had leaks used a greater staple height
(4.1–4.5 mm) on the lower stomach and a shorter staple
height 3.5 mm on the upper stomach as in the leakless
groups. Five groups used staple-line reenforcement on all
their patients. These five publications present 675 patients
with a total of 20 leaks, a leak rate of 3%. On the contrary,
Fig. 1 Medline search was completed starting with the keywords
‘‘sleeve gastrectomy’’ or ‘‘gastric sleeve’’ and ‘‘leak’’
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Table 1 Complications after sleeve gastrectomy
Study Year n BMI IOLT Leak % Location POD MGT
Johnston [12] 2003 100 46.3 ND 1 1 Prox ND OR
Han [17] 2005 130 37.2 MB 1 1 ND ND ND
Cottam [1] 2006 126 65.4 ND 2 2 NA ND ND
Roa [18] 2006 62 41.4 ND 1 2 ND 1 OR
Lalor [19] 2007 148 44 ND 1 1 Prox 1 OR
Lee [10] 2007 216 49 MB 3 1 ND ND OR
Nocca [20] 2007 163 45.9 MB 9 6 ND ND OR
Weiner [11] 2007 120 60.7 MB 3 3 ND 2 early/l OR
Felberbauer [3] 2008 126 48.1 ND 0 0 NA NA NA
Frezza [5] 2008 53 53.5 ND 2 4 ND ND OR
Kasalicky [21] 2008 61 42 MB 0 0 NA NA NA
Mui [22] 2008 70 40.8 MB 1 1 Prox 28 d Stent
Rubin [23] 2008 120 43 ND 0 0 NA NA NA
Skrekas [24] 2008 93 46.9 MB 4 4 ND ND OR
Burgos [25] 2009 214 37.8 MB 7 3 6 prox/1 dist 4 early/3 OR/tpn
Chowbey [9] 2009 75 58 MB 0 0 NA NA NA
Fuks [16] 2009 135 49 MB 7 5 Prox 4 OR
Goitein [26] 2009 55 45 ND 0 0 NA NA NA
Kakoulidis [27] 2009 79 34 ND 1 1 Prox late Stent
Menenakos [28] 2009 261 45.2 ND 10 4 Prox ND OR/stent
Sanchez [7] 2009 540 43.1 ND 11 2 ND ND tpn/OR
Stroh [6] 2009 144 54.5 ND 10 7 ND ND OR
Armstrong [29] 2010 185 44 None 0 0 NA NA NA
Csendes [30] 2010 343 37.5 MB 16 5 14 prox/2 dist 11 early/5 OR/tpn
Dapri [13] 2010 75 47 Air 4 5 2 prox/2 dist [10 days stent
Lacy [31] 2010 294 49.9 ND 11 4 11 prox [11 days OR
Ser [32] 2010 118 38 Air 4 3 Prox ND OR
Srinivasa [4] 2010 253 50 Air 6 2 ND ND OR
Bellanger [8] 2011 529 44 ND 0 0 NA NA NA
Study Year Stapler Buttress Bougie OR Bleed Stricture Location POD %EWL
Johnston [12] 2003 ND No 30–36-Fr ND 0 0 NA NA 58
Han [17] 2005 ND No 48–Fr ND 1 0 ND ND 83
Cottam [1] 2006 3.5 Tisseel 46–50-Fr 143 0 5 ND ND 45
Roa [18] 2006 4.1/3.5 Suture 52–Fr 80 0 0 NA NA 53
Lalor [19] 2007 4.5/3.5 Suture 44–52-Fr ND 1 1 Iincisura 3 w ND
Lee [10] 2007 4.8/3.5 Yes 32-Fr 66 0 0 NA NA 59
Nocca [20] 2007 4.1/3.1 ND ND ND 1 2 ND ND 59
Weiner [11] 2007 4.1/3.5 SG/PS/vic 32–44-Fr 75 1 0 NA NA ND
Felberbauer [3] 2008 4.5/3.5 PDS 48-Fr ND 0 1 ND 10 m [50
Frezza [5] 2008 4.1/3.5 PS/SG 29–34-Fr 70 1 0 NA NA 52
Kasalicky [21] 2008 3.5 No 38-Fr 105 1 0 NA NA ND
Mui [22] 2008 4.8 No 32-Fr NA 0 1 Incisura lm 63
Rubin [23] 2008 4.1/3.5 Suture 48-Fr 100 0 0 NA NA ND
Skrekas [24] 2008 3.5 Suture 36-Fr 121 0 0 NA NA 67
Burgos [25] 2009 4.1/3.5 Maxon 32–38-Fr ND 0 0 NA NA ND
Chowbey [9] 2009 4.1/3.5 SG 36-Fr 60 0 0 NA NA 59
Fuks [16] 2009 4.8/3.5 No 34-Fr 103 0 0 ND ND 59
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five groups document that they did not reenforce the staple-
line by any means. These represent 16 leaks out of 688
patients, or 2.3%. Nine groups oversewed their staple-line
every time. The oversewed groups had 1,891 patients with
56 leaks, a 3% leak rate. All patients had significant excess
weight loss ranging from 50 to 100% among the group of
studies that documented leaks.
Fourteen of the 29 studies did not document their
intraoperative leak test. Of those studies that did document
a leak test, 62% used methylene blue.
Seventeen of 22 groups that described leaks took the
patients back to the operating room (OR) for management
often in combination with stent and drain placement.
Eighteen of the publications document OR time, which
ranged from 58 to 143 min.
Discussion
The seduction of surgeons by sleeve gastrectomy is due to
its multiple advantages: less complex laparoscopic proce-
dure, no enteric anastomosis and no risk of internal hernia,
dumping syndrome, or marginal ulcer. In addition, sleeve
gastrectomy decreases the level of ghrelin hormone, has a
less malnutritive effect, allows continued endoscopic
access to the pancreaticobiliary system, and provides
comparative weight loss and subsequent resolution of
comorbidities that parallels gastric bypass surgery. Several
studies now have demonstrated that the laparoscopic sleeve
gastrectomy is safe and provides similar weight loss and
resolution of comorbidities to that of duodenal switch or
Roux-en-Y gastric bypass [2, 7]. Bellanger et al. recently
published their results of 529 patients without leaks and
%EWL of 68% at 1 year [8]. Chowbey et al. also had no
leaks in their 75 patients with a mean %EWL of 59% at
1 year postoperatively [9]. Their mean OR time was
60 min. Similarly, Lee et al. demonstrated %EWL of 59%
after 1 year follow-up of 216 patients with a mean BMI of
49 kg/m2 and had a leak rate of only 1.4% [10].
Major complications were significantly less for sleeve
gastrectomy patients (4.6%) compared with patients who
had laparoscopic gastric bypass (10.6%) or duodenal
switch (39.3%) by the same surgeons [10]. Preoperative
weight and BMI were greater in the sleeve patients in this
study. The sleeve patients had a greater overall weight loss
than patients who had laparoscopic gastric bypass or duo-
denal switch, but %EWL was greater in the gastric bypass
and duodenal switch patients. %EWL may be deceivingly
lower in the sleeve group. This can be explained because
patients with more excess weight preoperatively will have
a lower %EWL even though they may have lost more
actual weight than a patient with less excess weight pre-
operatively. Finally, a smaller study of 26 patients has
published data with stable excess weight loss of 55% as
well as significant decrease in ghrelin activity from 593 to
257 pg/ml at 5 year follow-up [2]. These results are mir-
rored by our analysis of 4,888 patients, demonstrating an
overall leak rate of 2.4% and consistent excess weight loss
of greater than 50%.
From our analysis of the literature, leak occurs from
0–7% of sleeve gastrectomy cases. There does appear to be
a significantly higher leak rate in patients with a
BMI [ 50 kg/m2. From the 29 publications analyzed, we
see a leak rate of 3% in the super-obese patient population
[1, 4–6, 9, 11]. This is similar to the increased risk of leak
in super-obese patients after gastric bypass. However,
Cottam et al. performed 126 sleeve gastrectomies on
patients with a mean BMI 65.3 kg/m2 with only two leaks
Table 1 continued
Study Year Stapler Buttress Bougie OR Bleed Stricture Location POD %EWL
Goitein [26] 2009 ND No 32–46-Fr 120 0 0 NA NA ND
Kakoulidis [27] 2009 4.1/3.5 Suture 32-Fr 75 2 0 NA NA 100
Menenakos [28] 2009 4.1/3.5 PS 38-Fr 58 0 0 NA NA 65.7
Sanchez [7] 2009 4.1/3.5 Suture 32–38-Fr ND ND 1 ND ND 63
Stroh [6] 2009 ND 0.5 32-Fr 93 2 1 ND ND ND
Armstrong [29] 2010 4.1/3.5 No 40-Fr 111 2 0 NA NA 47
Csendes [30] 2010 4.8/3.5 Maxon 38-Fr ND 8 3 Incisura ND ND
Dapri [13] 2010 4.8/3.5 PDS 34-Fr ND 0 ND ND ND ND
Lacy [31] 2010 4.1/3.5 Suture 32-Fr ND 3 3 2 inc/1 eg Late ND
Ser [32] 2010 4.8/3.5 Suture Endo 118.5 0 1 ND ND 81.5
Srinivasa [4] 2010 ND No 36-Fr 106 5 3 ND ND ND
Bellanger [8] 2011 4.1/3.5 No 34-Fr ND ND ND ND ND 68
BMI body mass index, MGT management, Stapler stapler leg length, Bougie Bougie size, OR operative time, POD postoperative day, %EWL %
excess weight loss, ND not disclosed, NA not applicable, PS Peri-Strips, SG Seamguard, IOLT intraoperative leak test
1512 Surg Endosc (2012) 26:1509–1515
123
(1.6%) [1]. They only used blue load staples (3.5 mm)
compared with most other groups who use 4.1–4.8 mm
staples on the antrum.
Two other factors that may have influenced their
favorably low leak results are that they used Tisseel on
all their staple-lines and they used a larger bougie size
(46–50-Fr) in general compared with most groups. Fibrin
glue also was used to cover the staple-line by Bellanger
et al. [8] who recently published their study of 529 cases
without a leak. Fibrin glue has been used for endoscopic
therapy of postoperative leaks after sleeve gastrectomy but
has not been documented as a regularly used product to
prevent leak in sleeve gastrectomy. The evidence for the
use of fibrin glue is currently limited and will require larger
studies before a fair judgment of its utility in preventing
leak in sleeve gastrectomy can be determined. Alterna-
tively, using a larger bougie size may give greater clear-
ance at the dreaded esophagogastric junction thereby
reducing the risk of leak. This may be supported by the fact
that surgeons who used a bougie size of 40-Fr or greater
had a 0.6% leak rate (5/897 cases). The leak rate was 2.8%
(110/3,991) in groups who used a bougie size \ 40-Fr
(P \ 0.05). This difference was statistically significant,
thus favoring the use of a bougie of 40-Fr to avoid leak.
This difference was independent of BMI. Weiner et al.
have demonstrated that bougie size, 32-Fr vs. 44-Fr, does
not have a significant influence on weight loss after sleeve
gastrectomy [12]. Interestingly, even though Cottam et al.
used one of the larger bougie sizes, 46–50-Fr, this group
presented with the most strictures 5/126 (4%). This is
counterintuitive, because larger bougie size is usually
employed to avoid stricture formation. The authors explain
that oversewing the staple-line in their initial sleeve
experience was the likely culprit. Once they switched to
using fibrin glue, they no longer experienced stricture.
Stricture is an uncommon but well-recognized risk after
sleeve gastrectomy. The mean stricture rate for the col-
lection of publications analyzed was 0.5% (22/4,284).
Stricture rate was not significantly different between
groups who oversewed the staple-line: 0.5% (10/2,137)
compared with 0.4% (4/989) for those who did not oversew
the staple-line. Admittedly the rate of stricture is so low
that it is difficult to see any difference between treatments.
Similarly, the use of reenforcement strips and oversewing
does not seem to decrease the already low incidence of
clinically significant bleeds. The overall bleed rate that
required surgical intervention was 0.7% (38/3,819). When
exclusively comparing groups that oversewed the staple-
line or used reenforcement strips the bleed rate was 0.9%
(15/1,672). This was the same for groups that did not use
any type of staple-line protection: stitch or strip (9/989).
Dapri et al. reiterated our findings in their prospective,
randomized trial that compared staple-line buttressing,
oversewing with unprotected staple-line [13]. This was a
small study of 25 patients per group that demonstrated no
difference in leak. The authors suggest that staple-line
buttressing decreases bleeding; however, the decrease was
from 60 to 30 ml on average per case. The clinical sig-
nificance of this is questionable. Due to the overall low
incidence of bleeding and stricture after sleeve gastrec-
tomy, it was not possible to discern a type of association
with leak from the data available.
The analysis of the data clearly suggests that leak pri-
marily occurs at the proximal portion of the staple-line.
Only 52% of studies documented the location of the leak
and 89% of these were at the esophagogastric junction.
This danger zone may be thinner than the rest of the
stomach. Elariny et al. demonstrated that the stomach has
different thickness throughout with the fundus being the
thinnest at approximately 1.7 mm [14]. This begs the
question of whether a white load (2.5 mm staple height)
should be used for the upper most staples as green loads are
used for the antrum because of its thickness.
Certain groups advocate measures to avoid stapling too
close to the esophagogastric junction and have had success
in eliminating leaks [8]. Many factors may contribute to the
success of Bellanger et al. [8], but it is difficult to tease out
one that is most responsible for their success. They discuss
the principles for reducing risk of leak, which are reiterated
throughout much of the literature on sleeve gastrectomy
and are as follows: assure good staple formation by
allowing time for tissue compression, avoid creating a
stricture by not stapling too close to the incisura, and avoid
stapling too close to the GE junction. There is no evidence
available that directly addresses any of these items spe-
cifically but rather observations and comments found
throughout the sleeve literature.
Timing of leak is very important. Of the 52 leaks that
had a documented time of diagnosis, 40 were more than
10 days postoperatively and thus required rehospitaliza-
tion. This suggests that approximately 79% of leaks will
occur as a late event, and the majority will be managed by
minimally invasive means, including endoscopic stenting.
Oshiro et al. published that operative management often
fails to resolve the leak due to poor tissues and inflam-
mation [15]. Operative management is useful for debride-
ment and drainage, but closure of the defect usually fails
due to the poor tissues. Fuks et al. found that regardless of
their experience, leak was a significant risk in the super-
obese [16]. They had seven leaks of 135 cases, six of which
went back to the OR and all required reintervention and
endoscopic stenting. Endoscopically placed stents com-
bined with percutaneous drainage and a short duration of
parenteral nutrition usually provide a good result. Some
have used endoscopically placed fibrin glue with variable
success [33].
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Conclusions
Our analysis has demonstrated that laparoscopic sleeve
gastrectomy provides comparative weight loss to gastric
bypass with minimal risk. Sleeve gastrectomy can be per-
formed successfully with a leak rate of approximately 2.4%
and clinically significant bleeding and stricture rate of less
than 1%. Leak occurs at the esophagogastric junction in
89% of the time, and very often the diagnosis occurs after
the patient has already been discharged.
The risk of leak is greater in patients with BMI [ 50
kg/m2. Bougie size of \40-Fr also is associated with
increased risk of leak. Oversewing or buttressing of the
staple-line does not have a clinically significant effect on
leak. Management of early leak should not be delayed and
is most effectively treated by operative or percutaneous
drainage and endoscopic stenting. Late leak often can be
managed by percutaneous drainage and endoscopic stent-
ing. Sufficiently powered, prospective, randomized studies
are needed to evaluate the role of fibrin glue, staple height,
and distance between the GE junction and the staple-line
independently and in combination on leak and complica-
tion after laparoscopic sleeve gastrectomy. The present
systematic analysis has provided a starting point for
designing studies that address points of interest to bariatric
surgeons.
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